Gelatin sponge impregnated with hemocoagulase reduces postoperative blood loss of patients with lumbar fractures undergoing posterior spinal decompression

doi:10.3969/j.issn.2095-4344.2014.34.021

Abstract

Abstract:

BACKGROUND: A single hemostatic material has been proved not to facilitate wound healing or to produce certain adverse reactions; while composites composed of two or three different materials can improve the advantage and histocompatibility of hemostatic materials.

OBJECTIVE: To investigate the effect of gelatin sponge impregnated with hemocoagulase solution on amount of bleeding in patients with lumbar fractures undergoing posterior spinal decompression.

METHODS: Fifty patients with lumbar fractures who were scheduled for open reduction, pedicle screw fixation and laminectomy were enrolled, including 25 cases treated with gelatin sponge impregnated with hemocoagulase before surgical incision closure as test group and 25 cases treated with single gelatin sponge before surgical incision closure as control group. Postoperative drainage volume, drainage time, length of stay, number of re-admissions and postoperative complications were compared between the two groups.

RESULTS AND CONCLUSION: The postoperative drainage volume, drainage time and length of stay in the test group were significantly less than those in the control group (P < 0.000 1). No infection, epidural hematoma, or re-admission of patients was found, and there was no hemocoagulase-impregnated absorbable gelatin sponge- related adverse reaction. These findings indicate that posterior laminectomy with hemocoagulase-impregnated gelatin sponge can significantly reduce patients’ postoperative wound drainage and shorten the length of stay.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

全文链接：

Key words: gelatin sponge, absorbable, hemostasis, decompression, surgical

CLC Number:

R318

Du Jun-sheng, Wang Guang-yong, Zhong Bing. Gelatin sponge impregnated with hemocoagulase reduces postoperative blood loss of patients with lumbar fractures undergoing posterior spinal decompression[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(34): 5530-5534.

Figures/Tables 1

References

[1] Schwartz SL,Hemostasis surgical bleeding,and transfusion.In:Schwartz SL,Shires GT,Spencer FC, eds. Principles of surgery.5thed.New York:McGraw-Hill, 1989: 105-135.
[2] 杨德林,张妍,岳武,等.几种止血材料在肝脏创伤中的应用研究[J].中华创伤杂志,2004,20(2):111-112.
[3] Wu J,Jin Y,Zhang J,et al.Hemostatic Techniques Following Multilevel PosteriorLumbar Spine Surgery: A Randomized Control Trial.J Spinal Disord Tech. 2013. [Epub ahead of print]
[4] 李学军,孙园园.不同生物止血材料研究进展及复合型止血材料的临床应用[J].中国组织工程研究与临床康复, 2011,15(51): 9671-9674.
[5] 施子禄,林沁,陈建.局部止血药物与材料的临床应用概况[J].中国药房,2007,18(4):307.
[6] 汪向飞,张晓丹,周汉新.生物医用可吸收止血材料的研究与临床应用[J].中国组织工程研究与临床康复, 2010,14(21):3973-3976.
[7] Ziv-Polat O,Topaz M,Brosh T,et al.Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials.2010;31(4):741-747.
[8] 武继民,李荣,王岩.胶原海绵作为止血和创面敷料的临床实验[J].生物医学工程与临床,2003,9(7):152-154.
[9] 肖荣冬,翁国星.胶原/透明质酸膜与明胶海绵支架材料力学及组织相容性的比较[J].中国组织工程研究, 2012,16(25):4637- 4643.
[10] 何艳新,刘超.可吸收材料生物蛋白胶及明胶海绵在肝部分切除的应用[J].中国组织工程研究,2012,16(12):2180-2182.
[11] 张巍,张元和.脂肪干细胞与可吸收明胶海绵的组织相容性[J].中国组织工程研究, 2013,17(40):7047-7053.
[12] 康佐文,时凯,黄国章.立止血的酶学特性及其作用机理[J].蛇志, 2001,13(1):59-61.
[13] Itoh N,Tanaka N,Misi S,et al.Molecular cloning and sequence analysis of cDNA for Batroxobin,a thrombin-like snake venom enzyme.J Biol Chem.1987;262(7):3132-3135.
[14] 邢宝才,宋军民.外科引流的合理应用[J].中国实用外科杂志, 2007, 27(1):48-50.
[15] 赵士海,胡庆柳,钟志勇,等.胶原/纤维蛋白止血效果观察[J].中国比较医学杂志,2010,20(5):61-65.
[16] 霍雷,阮文华,丁志良,等.新型止血材料SURGICELTM和明胶海绵在神经外科手术中的应用[J].中国组织工程研究, 2012, 16(3): 551-554.
[17] Alam HB,Burris D,DaCorta JA,et al.et al.Hemorrhage control in the battlefield: role of new hemostatic agents.Mil Med. 2005; 170(1):63-69.
[18] 潘华,周元聪,杨冠珍,等.蝮蛇类凝血酶基因的分析及表达研究[J].生物化学与生物物理学报,1999,31(1):79-82.
[19] Hofmann H,Bon C.Blood coagulation induced by the venom of Bothrops atrox. 2. Identification, purification, and properties of two factor X activators.Biochemistry. 1987;26(3):780-787.
[20] 安海水,姚军,王红杰.血凝酶不同给药方法用于脊柱手术止血效果[J].中国新药与临床杂志,2004,23(7):390-392.
[21] 何锡强,汪蓓,赵辉,等.注射用血凝酶对髋关节置换术患者围术期出凝血功能影响的研究[J].中华创伤外科杂志, 2004,20(11): 685-687.
[22] Guan LF,Chi CW,Yuan M.Study on the thrombin-like enzyme preferentially releasing fibrinopeptide B from the snake venom of Agkistrodon halys Pallas.Thromb Res. 1984;35(3): 301-310.
[23] Zhang Y,Lee WH,Gao R,et al.Effects of Pallas ' viper . (Effects of Pallas' viper (Agkistrodon halys pallas) venom on blood coagulation and characterization of a prothrombin activator.Toxicon.1998;36(1):143-152.
[24] Alam HB,Burris D,DaCorta JA,et al.Hemorrhage control in the battlefield:role of new hemostatic agents.Mil Med. 2005; 170(1): 63-69.
[25] Belman A,Daya M,Stevens M,et al.From the battlefield to the street-experience of a suburban fire/EMS agency with chitosan dressing. Hemostatic Management. 2006;12(3): 46-47.
[26] Petrowsky H,Demartines N,Rousson V,et al. Evidence-basedvalue of prophylactic drainage in gastro in test inal surgery a systematic reiew and metaeta-analyses. Ann Surg.2004;240(6):1074-1084.
[27] 梅枭雄,范承启,张继超,等.医疗条件缺乏环境下的创伤止血药物(材料)研究现状[J].中国药房,2012,23(13):1232-1233.
[28] 卢斌,钱利强,章志量.壳聚糖止血机理及应用进展研究[J].健康研究,2010,30(1):55-58.
[29] Pozza M,Millner RW.Celox (chitosan) for haemostasis in massive traumatic bleeding: experience in Afghanistan.Eur J Emerg Med.2011;18(1):31-33.
[30] 张伟.几丁质及其衍生物促进创面愈合的作用[J].中国矫形外科杂志,2000,7(3):277.
[31] 庞迪,张亚新.新型生物止血材料-医用生物蛋白胶临床应用的效果观察[J].山东生物医学工程,2003,22(1):44-45.
[32] 王莲莲,汤智怡,罗娜.生物止血材料在妇产科手术中的应用[J].中国组织工程研究与临床康复,2011,15(29):5441-5444.
[33] 周忠笑,魏晰麟,姚建茹,等.生物止血敷料及纱布在外科伤口中的应用评价[J].中国组织工程研究与临床康复, 2010,14(51): 9635-9638.
[34] 张德兴,何忠杰.伤口止血材料研究进展[J].中国急救医学, 2005, 5(25):353-355.
[35] 邓春梅,何兰珍,杨丹,等.壳聚糖-明胶海绵伤口敷料的毒理学评价[J].毒理学杂志,2007,21(1):76-77
[36] 首家保,陈彬,芦慎,等.不同敷料修复创面的实验研究及临床应用评价[J].中国组织工程研究,2012,16(8):1479-1482.
[37] 王建,葛宝丰,刘兴炎,等.战伤止血方法及材料研究进展[J].人民军医,2008,51(1):5-6.
[38] Fiss I,Danne M,Stendel R.Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.Neurol Med Chir (Tokyo). 2007;47(10):462-467.
[39] 王勇,陆伟.体内可吸收止血材料研究及临床应用[J].生物医学工程学杂志,2009,26(4):922-926.
[40] 孙鸿涛,裴国献,王运斗,等.伤口急救保护剂对猪肢体创伤创面的止血研究[J].中华创伤骨科杂志,2003,5(4):291-295.
[41] Gazzeri R,Galarza M,Neroni M,et al.Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.Acta Neurochir (Wien).2011;153(1):148-154.
[42] Mathiasen RA,Cruz RM.Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.Otolaryngol Head Neck Surg. 2004;131(5):601-605.
[43] Nasso G,Piancone F,Bonifazi R,et al.Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg.2009;88(5):1520-1526.
[44] Weaver FA,Hood DB,Zatina M,et al.Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery.Ann Vasc Surg.2002;16(3):286-293.
[45] Yao HH,Hong MK,Drummond KJ.Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant? J Clin Neurosci.2013;20(3):349-356.